New Horizon Health

New Horizon Health PEG

Delisted·Feb 9, 2026

The PEG Ratio (Price/Earnings-to-Growth) of New Horizon Health (6606.HK) as of Oct 22, 2026 is -0.63.

PEG

-0.63

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of New Horizon Health is 2022 -0.63 . PEG Ratio (Price/Earnings-to-Growth) of New Horizon Health was 2021 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

New Horizon Health Stock analysis

What does New Horizon Health do? New Horizon Health Ltd. generates revenue through the distribution of its ColoClear and Pupu tube products via its own network, contracted sales organisations (CSOs), and e-platforms managed by healthcare clinics. The company also develops Youyou Tube, a stool-based self-checking gastric cancer screening test, and CerviClear, a non-invasive urine cervical cancer home screening test, which are currently under development. Its primary customers include healthcare clinics and end-users seeking non-invasive cancer screening solutions. The firm's product portfolio focuses on innovative medical screening tools, targeting the growing demand for accessible and user-friendly health diagnostics. By leveraging its internal sales channels and partnerships with CSOs, New Horizon Health Ltd. ensures broad market reach for its products. The company's development of Youyou Tube and CerviClear reflects its strategic emphasis on expanding into high-need areas of cancer prevention and early detection. Revenue streams are derived from the sale of ColoClear and Pupu tube products, with future potential from the commercialization of Youyou Tube and CerviClear once development is complete. The company's business model relies on direct and indirect sales channels to healthcare providers and consumers, positioning it within the medical diagnostics sector. New Horizon Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about New Horizon Health stock

PEG Ratio (Price/Earnings-to-Growth) of New Horizon Health is -0.63 in 2022.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) New Horizon Health since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s New Horizon Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — New Horizon Health

All Key Metrics — New Horizon Health